Eric Trump calls the XpresTest report 'an absolutely fake story' and says he will sue ProPublica

Eric TrumpExecutive vice president of the Trump Organization and an adviser to Dominari Holdings, in a post on his X account

Denied

Replying on X to Rep. Mike Levin, Eric Trump calls the report fake and slander, says a legal letter and his intent to sue ProPublica have been issued, says the company's relationship with the CDC dates to 2021, and says he has nothing to do with the company beyond a passive investment in an entity with a minority interest.

Responding to

XpresTest won its CDC Ebola entry screening contract and its State Department outbreak response award through competitive bidding.

“This is an absolutely fake story as usual—one of about 20 I have seen targeting anyone and everything Trump this week. A legal letter and my intent to sue ProPublica have already been issued (see below). Two minutes of research shows that this company’s relationship with the CDC occurred in 2021, under the Biden Administration. I have nothing to do with this company other than being a passive investor in an entity that has a minority interest. I have never spoken to them; I don’t know anybody from their management team, what they do, or who they are. Nothing. This is slander, and I will hold anyone— which will start with ProPublica—who suggests otherwise liable.”

Checked word for word against a linked source on .

Original post

Read the original post (opens in a new tab)Eric Trump (@EricTrump) on X, November 12, 2026: 'This is an absolutely fake story as usual' · Eric TrumpPost of November 12, 2026, quoting a post by Rep. Mike Levin

Original post

Read the original post (opens in a new tab)Mike Levin (@MikeLevin) on X, November 12, 2026: 'Their fund buys in, and federal money follows.' · Mike LevinPost of November 12, 2026

Reporting

Open source (opens in a new tab)ProPublica report on XpresTest's nearly $40 million in federal Ebola screening awards and its parent company's ties to Trump's sons · ProPublicaFull article

Case updates

Want the next important update?

Follow this case and get an email when an important development changes the record.

Important updates only. Free. Confirm your email to start. Unsubscribe anytime. How we handle your email.

A U.S. Coast Guard corpsman in a face shield, mask and blue gloves holds a thermometer up to a traveler, who is seen from behind, while another masked officer looks on.
Credit: Josh Denmark / U.S. Customs and Border Protection

Where this statement fits

XpresTest won more than $55 million in Ebola awards months after a fund tied to Trump's sons invested in its parent; the sons say they had no role

On November 9, 2026, ProPublica reported that XpresTest, the biosurveillance subsidiary of XWELL Inc., received an $18.8 million CDC contract to screen travelers for Ebola at U.S. airports and a $20 million State Department award for outbreak response in the Democratic Republic of Congo. Both came months after American Ventures, a fund launched by Dominari Holdings, invested about $30 million in XWELL. Dominari hired Donald Trump Jr. and Eric Trump as advisers and gave them a stake of more than 10%, according to ProPublica. XWELL's chief executive, Ezra Ernst, told ProPublica that XpresTest won both awards in competitive bidding. The federal award record for the CDC contract lists it as not competed, with one offer received, under the urgency exception in FAR 6.302-2. A modification signed November 6 exercises an option on that contract and brings its total obligations to $35.5 million, according to the federal procurement record. The State Department says its award was competitive. A spokesperson for the Trump sons says they are passive minority investors in the fund and had no involvement in the contracts.

Read the full case

Source and context

Original post

Eric Trump (@EricTrump) on X, November 12, 2026: 'This is an absolutely fake story as usual' (opens in a new tab) · Eric TrumpPost of November 12, 2026, quoting a post by Rep. Mike Levin

About this source

Eric Trump's reply on X to Rep. Mike Levin's post about the XpresTest awards. It quotes Levin's post and says he intends to sue ProPublica.

Original post

Mike Levin (@MikeLevin) on X, November 12, 2026: 'Their fund buys in, and federal money follows.' (opens in a new tab) · Mike LevinPost of November 12, 2026

About this source

A post from Levin's X account on ProPublica's report about XpresTest's federal Ebola screening awards and the fund tied to Donald Trump Jr. and Eric Trump that invested in its parent company. It links the ProPublica report.

Reporting

ProPublica report on XpresTest's nearly $40 million in federal Ebola screening awards and its parent company's ties to Trump's sons (opens in a new tab) · ProPublicaFull article

About this source

ProPublica reports that XpresTest, a subsidiary of XWELL, received an $18.8 million CDC contract for Ebola entry screening at U.S. airports and a $20 million State Department award for outbreak response in the Democratic Republic of Congo, months after American Ventures, a fund launched by Dominari Holdings, invested about $30 million in XWELL. It includes responses from the State Department, a spokesperson for Donald Trump Jr. and Eric Trump, Dominari's chief executive and XWELL's chief executive.

Archived copy (opens in a new tab)

Before the quotation

Eric Trump wrote the post as a reply quoting Levin's post from earlier that day, which said federal money follows the Trump-linked fund's investments and called it "all totally corrupt."

After the quotation

ProPublica reports that during the COVID-19 pandemic the company, then known as XpresSpa Group, got $5.5 million from the CDC to offer travelers COVID-19 testing, and that XpresTest was awarded the CDC contract for Ebola entry screening services in June 2026.

How this statement is classified

Denied

The label describes this statement's response within the context above.

Why this label?

Eric Trump says he has never spoken to the company or anyone on its management team and has no tie to it beyond a passive investment, and calls the report slander, so we labeled it Denied.

Recorded on
Published here
People and groups discussed
Mike Levin, ProPublica

More from this case

Read the full case

Scott Dworkin says the CDC's Ebola contract with XpresTest was 'NOT COMPETED' and has since grown

Scott Dworkin

“ProPublica showed this week exactly the type of thing Congress should be looking at. In February, an investment fund linked to Trump’s sons put about $30 million into a company called XWELL. Months later, the regime handed XWELL’s testing business nearly $40 million in contracts to screen for Ebola and other diseases. A spokesperson for Trump’s sons told ProPublica they are passive investors who had no involvement in the contracts. XWELL’s CEO told ProPublica the company won through competitive bidding. So I pulled the CDC contract’s records myself. They say “NOT COMPETED.” Only one offer came in. Then on November 6, the CDC chose to put $16.7 million more into the same contract. That money isn’t in the figure reported this week. It brings the total to $55.5 million.”
Read statement

Share or embed this statement

Quote card: Eric Trump, Eric Trump calls the XpresTest report 'an absolutely fake story' and says he will sue ProPublicaDownload image (PNG)

The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the statement page.

Cite this record

Publisher
The Dispute Index
Title
Eric Trump calls the XpresTest report 'an absolutely fake story' and says he will sue ProPublica
First published
Last updated
Permalink
https://disputeindex.com/events/9088-replying-on-x-to-rep-mike-levin-eric

Last updated marks the most recent saved version of this published statement.

The Dispute Index. "Eric Trump calls the XpresTest report 'an absolutely fake story' and says he will sue ProPublica". First published: 2026-11-15. Last updated: 2026-11-15. https://disputeindex.com/events/9088-replying-on-x-to-rep-mike-levin-eric